First Wave BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 04:17 pm EDT
First Wave BioPharma, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 4.19 million compared to USD 5.41 million a year ago. Basic loss per share from continuing operations was USD 37.8.
For the six months, net loss was USD 8.26 million compared to USD 15.03 million a year ago. Basic loss per share from continuing operations was USD 62.